Medroxyprogesterone Acetate

Product NDC: 70518-3070
Requested package NDC: 70518-3070-1
11-digit product format: 705183070
Labeler code: 70518
Product ID: 70518-3070_efb80511-4283-024c-e053-2a95a90af004
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Medroxyprogesterone Acetate
Dosage form: TABLET
Route: ORAL
Labeler: REMEDYREPACK INC.
Application: ANDA040159
Marketing category: ANDA
Marketing start: 2021-04-10
Marketing end: 0000-00-00
Substance: MEDROXYPROGESTERONE ACETATE
Active strength: 10 mg/1
Pharmacologic classes: Progesterone Congeners [CS], Progestin [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	70518-3070	70518-3070-1	D	Discontinued by firm		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 11 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A040159-001	MEDROXYPROGESTERONE ACETATE	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09
A040159-002	MEDROXYPROGESTERONE ACETATE	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09
A040159-003	MEDROXYPROGESTERONE ACETATE	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A040159-001	AB
A040159-002	AB
A040159-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A040159-002	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A040159-003	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040159-002	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040159-003	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A040159-002	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A040159-003	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040159-002	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040159-003	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040159-002	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040159-003	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040159-002	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040159-003	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040159-002	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040159-003	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040159-002	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040159-003	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040159-002	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040159-003	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A040159-002	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A040159-003	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040159-002	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040159-003	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040159-002	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040159-003	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040159-002	MEDROXYPROGESTERONE ACETATE	5MG	TABLET / ORAL	AB	1996-08-09	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040159-003	MEDROXYPROGESTERONE ACETATE	10MG	TABLET / ORAL	AB	1996-08-09	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040159-001	MEDROXYPROGESTERONE ACETATE	2.5MG	TABLET / ORAL	AB	1996-08-09	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A040159-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A040159-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A040159-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040159-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040159-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040159-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040159-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A040159-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A040159-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040159-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040159-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040159-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040159-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040159-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040159-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040159-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040159-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040159-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040159-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040159-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040159-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040159-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040159-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040159-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040159-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040159-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040159-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040159-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A040159-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A040159-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040159-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040159-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040159-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040159-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040159-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040159-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040159-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040159-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040159-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040159-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: Medroxyprogesterone Acetate
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
MEDROXYPROGESTERONE ACETATE	10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
C2QI4IOI2G	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1000114	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
e3dfd683-d44e-427b-af06-70b9b698e016	Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 20 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	REMEDYREPACK INC.	e3dfd683-d44e-427b-af06-70b9b698e016	2026-07-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159 ndc (package): 70518-3070-1 ndc (product): 70518-3070 ndc11 (package): 70518307001
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Preferred Pharmaceuticals Inc.	a9e05272-aa4e-4df8-b08b-481abca3e8fd	2026-06-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Preferred Pharmaceuticals, Inc.	37275fd0-eb24-40a4-a93f-b818bb98414e	2026-06-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	REMEDYREPACK INC.	1020bb60-4f13-4cd7-aaa1-c556752c84b7	2026-05-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	A-S Medication Solutions	816b9fd2-bc55-496b-846a-cabe7bbdecd6	2026-01-06	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Northwind Health Company, LLC	0de6142f-a78e-ae58-e063-6394a90adff0	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	American Health Packaging	cbf142f9-9af3-4d79-9343-0ab42d6dbe9f	2025-11-13	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	PD-Rx Pharmaceuticals, Inc.	6a541749-5d14-44aa-a409-5e51f5bbf929	2025-10-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	A-S Medication Solutions	bfdf335d-1cbb-4533-9fde-99a9c71f7504	2025-06-12	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	A-S Medication Solutions	788df737-e990-4b5e-accd-af13c3b2bf8b	2025-06-12	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Coupler LLC	2cf48919-6de8-d3d0-e063-6394a90ac1bc	2025-01-30	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	PD-Rx Pharmaceuticals, Inc.	437edd12-2c08-4df4-8cf7-64c47e4779ac	2025-01-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Bryant Ranch Prepack	a36c89b7-9463-4d00-a4d3-021d77090077	2024-07-08	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Bryant Ranch Prepack	a88b33ff-842b-4a5b-a27e-9c2b9e85a4d7	2024-07-08	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Bryant Ranch Prepack	bdb89690-ced2-48e1-bb1a-e5eccfeda8eb	2024-07-08	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Bryant Ranch Prepack	d9ad130b-8f9a-4a0f-beb4-b692b6d3c5ca	2024-07-08	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	NuCare Pharmaceuticals,Inc.	5c8ffae3-3b3e-197e-e053-2a91aa0a59e3	2024-06-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Teva Pharmaceuticals USA, Inc.	9eb200b0-db96-4a51-87ea-04db862978c8	2024-03-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Proficient Rx LP	0df6fd1e-7d9c-4a38-848c-1e562e211c91	2023-02-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159
Medroxyprogesterone	MEDROXYPROGESTERONE	PharmPak, Inc.	1403a9a9-c04a-432f-8819-4850f779312e	2022-10-09	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040159 application number: ANDA040159

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
C2QI4IOI2G	MEDROXYPROGESTERONE ACETATE	71-58-9	MEDROXYPROGESTERONE ACETATE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
70518-3070-1	70518307001	30 TABLET in 1 BLISTER PACK (70518-3070-1)	30 tablet	2021-11-11	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
MedroxyPROGESTERone Acetate Tablets, USP	REMEDYREPACK INC.	2026-07-20	HUMAN PRESCRIPTION DRUG LABEL	7